El reto de generar protección cruzada frente a coronavirus pandémicos
Instituto de Investigación Sanitaria Bioaraba
Gasteiz, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Bioaraba (5)
2024
-
Liposome-based peptide vaccines to elicit immune responses against the membrane active domains of the HIV-1 Env glycoprotein
Biochimica et Biophysica Acta - Biomembranes, Vol. 1866, Núm. 1
-
On the antimicrobial properties and endurance of eugenol and 2-phenylphenol functionalized sol-gel coatings
Heliyon, Vol. 10, Núm. 8
2023
-
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo
Science translational medicine, Vol. 15, Núm. 697, pp. eadf4549
-
Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses
Cell Reports, Vol. 42, Núm. 4
2022
-
Molecular recognition of a membrane-anchored HIV-1 pan-neutralizing epitope
Communications Biology, Vol. 5, Núm. 1